Setup. Insight Enterprises (NSIT, $2.1B) is an IT solutions integrator the market has spent 18 months treating as a fading low-margin VAR — stock -47% 1Y, trading 6.0x forward earnings vs peer CDW at ≈16x. Q1 2026 10-Q filed May 7. CDW filed its 10-Q May 6. Reading them side by side, NSIT gross margin (21.7%) exceeded CDW (21.0%) for the first time in recent history. The cohort just inverted in 24 hours and the multiple gap hasn't moved.

What the filings say.

NSIT Q1 2026:

• GM 21.7%, +240bps YoY. New quarterly record above FY2025 full-year record of 21.4%.
• Services gross profit $283.2M, +22.9% YoY. NA Software -28% (cloud migration / principal-to-agent shift); NA Hardware +6%.
• Agency-basis revenue $208.7M, +22.9%. Netted-down costs flowing through balance sheet $4.5B vs $2.7B Q1 2025 (+67%).
• NA Public Sector $161.7M, +10.2% YoY. CNXN federal -72.9% same quarter; CDW Government +4.6%.
• EPS $2.88 vs $2.44 estimate (+17.9% beat). Adj EFO $141.1M, margin 6.6% vs 5.3%.
• Earnout fair-value reval loss $25.3M in Q1 alone (= full FY2025 total). Non-deductible, drives 39.4% tax rate. Inspire11/Sekuro periods through 2027.
• OCF $32.4M vs $78.1M Q1 2025 (-58%). MD&A attributes to working capital + agency-flow timing.
• ABL drew up $112M to $976M, explicitly to fund $75M buyback at $83.37 average. Interest expense +51% YoY.
• CEO Jack Azagury (29yr Accenture, $15B P&L) effective April 13. $10M inducement PSUs require 118-200% stock-price growth in 3 years.

CDW Q1 2026 (same week):

• GM -60bps to 21.0%. Both Commercial (-60bps) and Government (-260bps) compressed. MD&A explicit: "a lower contribution of netted down revenue."
• Services revenue +0.25% YoY (essentially flat). Services as % of revenue declined from 9.2% to 8.5%.

NSIT moves opposite to CDW on the same accounting mechanism, same investor base, same week.

What the market thinks.

Price $70.37, mkt cap $2.1B, fwd P/E 6.0x on consensus FY26 ≈$11.65. Mean target $101.25 (JPM Underweight $80, Barrington Outperform $120). ATM IV 81.5% at 141st percentile. P/C 0.11 (bullish skew). Short interest 7.2% (down from 11.7% mid-March). Max pain $65.

Implied gap: NSIT 6x vs CDW ≈16x → ≈165% upside if convergence. Mean analyst target at 9.5x = "partial re-rating, not full convergence." Options-implied 12mo σ ≈80% (capitulation overpriced).

Why the gap exists.

1. Cross-ticker not synthesized. CDW and NSIT are covered in separate verticals (large-cap IT services vs SMID). Reading two 10-Qs filed 24 hours apart with opposite GM directions on the same agency-mix mechanism is a coverage-gap artifact, not a market efficiency.
2. Style overlay obscures idio. -47% 1Y momentum + 6x P/E screens as fading VAR. Forced-seller signature (RSI 27, capitulation through Jan-Mar) drove fundamental holders out before the cohort signal landed.
3. Trust deficit on Adj EFO. Definition expanded Q1 2026 to additionally exclude SBC ($8.2M/qtr). GAAP-to-Adj gap now ≈$70M/qtr (≈100% add-backs). Analysts who don't trust the metric won't apply CDW-equivalent multiples.
4. Earnout drag bunches. $25.3M Q1 reval = full FY2025. Bull and bear share the same root cause: acquisitions hitting plan drives both GM expansion AND non-deductible accounting drag.

Risks (ranked by impact).

1. Q2 GM compression below 20.5% — Q1 was one-quarter mix windfall, transformation thesis breaks.
2. Q2 OCF stays $30-50M — cash conversion structurally degrading as agency mix grows.
3. Earnout footnote shows accounting smoothing rather than acquisition outperformance — trust deficit cascades.
4. Negative momentum extends; heavy UMD loading means path pain real even with thesis intact.
5. DRAM/NAND shortage forces NSIT to absorb hardware margin to preserve customer relationships.
6. NA President not named — capacity concern at top of org.

Catalysts.

• Earnings call (next 1-2 days) — Azagury's first public communication; tone, federal commentary, FY26 reaffirmation.
• PLUS Q4 FY26 print (~early June) — federal-IT cohort bifurcation triangulator.
• NSIT Q2 print (~Aug 14) — GM, OCF, NA Public Sector durability all resolve same print.
• Azagury Form 4 open-market buy (any time) — would validate governance + operator alignment beyond inducement equity.

What would change our mind.

• Q2 GM ≥ 21.0% AND OCF ≥ $60M → cohort divergence durable.
• Q2 GM < 20.5% → transformation broken; fall back to fading-VAR base case.
• Earnout footnote with Inspire11/Infocenter/Sekuro EBITDA materially above plan → bullish (acquisitions hitting); accounting policy change on earnouts → bearish (smoothing).
• CDW Q2 GM continues compressing while NSIT holds ≥ 21% → cohort inversion confirmed structural.
• PLUS Q4 FY26 Public Sector ≥ 0% → federal-IT bifurcation graduates to calibration rule.

Evidence